acp clinical communications limited
acp clinical communications limited Company Information
Company Number
07933977
Next Accounts
Oct 2025
Industry
Other human health activities
Directors
Shareholders
dr anita chadha-patel
Group Structure
View All
Contact
Registered Address
the tall house 29a west street, marlow, buckinghamshire, SL7 2LS
Website
-acp clinical communications limited Estimated Valuation
Pomanda estimates the enterprise value of ACP CLINICAL COMMUNICATIONS LIMITED at £778.9k based on a Turnover of £1.7m and 0.46x industry multiple (adjusted for size and gross margin).
acp clinical communications limited Estimated Valuation
Pomanda estimates the enterprise value of ACP CLINICAL COMMUNICATIONS LIMITED at £750.9k based on an EBITDA of £205.6k and a 3.65x industry multiple (adjusted for size and gross margin).
acp clinical communications limited Estimated Valuation
Pomanda estimates the enterprise value of ACP CLINICAL COMMUNICATIONS LIMITED at £2.9m based on Net Assets of £1.2m and 2.47x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Acp Clinical Communications Limited Overview
Acp Clinical Communications Limited is a live company located in buckinghamshire, SL7 2LS with a Companies House number of 07933977. It operates in the other human health activities sector, SIC Code 86900. Founded in February 2012, it's largest shareholder is dr anita chadha-patel with a 100% stake. Acp Clinical Communications Limited is a established, small sized company, Pomanda has estimated its turnover at £1.7m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Acp Clinical Communications Limited Health Check
Pomanda's financial health check has awarded Acp Clinical Communications Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 3 areas for improvement. Company Health Check FAQs
6 Strong
1 Regular
3 Weak
Size
annual sales of £1.7m, make it larger than the average company (£640.3k)
- Acp Clinical Communications Limited
£640.3k - Industry AVG
Growth
3 year (CAGR) sales growth of 10%, show it is growing at a faster rate (7.2%)
- Acp Clinical Communications Limited
7.2% - Industry AVG
Production
with a gross margin of 21.5%, this company has a higher cost of product (36.1%)
- Acp Clinical Communications Limited
36.1% - Industry AVG
Profitability
an operating margin of 12.1% make it more profitable than the average company (5.5%)
- Acp Clinical Communications Limited
5.5% - Industry AVG
Employees
with 2 employees, this is below the industry average (17)
2 - Acp Clinical Communications Limited
17 - Industry AVG
Pay Structure
on an average salary of £25.5k, the company has an equivalent pay structure (£25.5k)
- Acp Clinical Communications Limited
£25.5k - Industry AVG
Efficiency
resulting in sales per employee of £848.5k, this is more efficient (£46.5k)
- Acp Clinical Communications Limited
£46.5k - Industry AVG
Debtor Days
it gets paid by customers after 142 days, this is later than average (22 days)
- Acp Clinical Communications Limited
22 days - Industry AVG
Creditor Days
its suppliers are paid after 23 days, this is slower than average (18 days)
- Acp Clinical Communications Limited
18 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Acp Clinical Communications Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Acp Clinical Communications Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 6.8%, this is a lower level of debt than the average (24.5%)
6.8% - Acp Clinical Communications Limited
24.5% - Industry AVG
ACP CLINICAL COMMUNICATIONS LIMITED financials
Acp Clinical Communications Limited's latest turnover from January 2024 is estimated at £1.7 million and the company has net assets of £1.2 million. According to their latest financial statements, Acp Clinical Communications Limited has 2 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | Jan 2015 | Jan 2014 | Jan 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||||||
| Other Income Or Grants | ||||||||||||
| Cost Of Sales | ||||||||||||
| Gross Profit | ||||||||||||
| Admin Expenses | ||||||||||||
| Operating Profit | ||||||||||||
| Interest Payable | ||||||||||||
| Interest Receivable | ||||||||||||
| Pre-Tax Profit | ||||||||||||
| Tax | ||||||||||||
| Profit After Tax | ||||||||||||
| Dividends Paid | ||||||||||||
| Retained Profit | ||||||||||||
| Employee Costs | ||||||||||||
| Number Of Employees | 2 | 2 | 2 | 1 | 1 | 1 | ||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | Jan 2015 | Jan 2014 | Jan 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 582,067 | 311,386 | 296,800 | 297,466 | 0 | 0 | 0 | 0 | 664 | 1,329 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,000 | 4,000 | 6,000 | 8,000 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 582,067 | 311,386 | 296,800 | 297,466 | 0 | 0 | 0 | 0 | 2,664 | 5,329 | 6,000 | 8,000 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 661,050 | 786,755 | 630,146 | 477,710 | 504,506 | 425,465 | 47,276 | 22,016 | 23,459 | 27,725 | 60,271 | 18,886 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 19,120 | 0 | 0 | 729 | 3,839 | 0 | 4,002 | 7,045 | 5,200 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 167,111 | 246,668 | 157,728 | 170,154 | 65,491 | 38,586 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 8,075 | 100,000 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 680,170 | 786,755 | 630,146 | 478,439 | 508,345 | 433,540 | 318,389 | 275,729 | 186,387 | 197,879 | 125,762 | 57,472 |
| total assets | 1,262,237 | 1,098,141 | 926,946 | 775,905 | 508,345 | 433,540 | 318,389 | 275,729 | 189,051 | 203,208 | 131,762 | 65,472 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 85,849 | 75,968 | 87,740 | 82,255 | 49,959 | 47,175 | 6,313 | 0 | 0 | 34,822 | 27,870 | 31,128 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 23 | 0 | 364 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 30,613 | 37,885 | 16,267 | 0 | 0 | 0 |
| total current liabilities | 85,849 | 75,968 | 87,740 | 82,255 | 49,959 | 47,198 | 36,926 | 38,249 | 16,267 | 34,822 | 27,870 | 31,128 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 985 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 985 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 85,849 | 75,968 | 87,740 | 82,255 | 49,959 | 48,183 | 36,926 | 38,249 | 16,267 | 34,822 | 27,870 | 31,128 |
| net assets | 1,176,388 | 1,022,173 | 839,206 | 693,650 | 458,386 | 385,357 | 281,463 | 237,480 | 172,784 | 168,386 | 103,892 | 34,344 |
| total shareholders funds | 1,176,388 | 1,022,173 | 839,206 | 693,650 | 458,386 | 385,357 | 281,463 | 237,480 | 172,784 | 168,386 | 103,892 | 34,344 |
| Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | Jan 2015 | Jan 2014 | Jan 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||
| Operating Profit | ||||||||||||
| Depreciation | 0 | 0 | 0 | 664 | 665 | 665 | 0 | 0 | ||||
| Amortisation | 0 | 0 | 0 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | ||||
| Tax | ||||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -106,585 | 156,609 | 151,707 | -29,906 | 82,880 | 374,187 | 22,217 | 402 | 934 | -32,546 | 41,385 | 18,886 |
| Creditors | 9,881 | -11,772 | 5,485 | 32,296 | 2,784 | 40,862 | 6,313 | 0 | -34,822 | 6,952 | -3,258 | 31,128 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | -985 | -29,628 | -7,272 | 21,618 | 16,267 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||||||||
| Investing Activities | ||||||||||||
| capital expenditure | ||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||||||
| Financing Activities | ||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | -23 | 23 | -364 | 364 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||
| interest | ||||||||||||
| cash flow from financing | ||||||||||||
| cash and cash equivalents | ||||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | -167,111 | -79,557 | 88,940 | -12,426 | 104,663 | 26,905 | 38,586 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | -167,111 | -79,557 | 88,940 | -12,426 | 104,663 | 26,905 | 38,586 |
acp clinical communications limited Credit Report and Business Information
Acp Clinical Communications Limited Competitor Analysis
Perform a competitor analysis for acp clinical communications limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in SL7 area or any other competitors across 12 key performance metrics.
acp clinical communications limited Ownership
ACP CLINICAL COMMUNICATIONS LIMITED group structure
Acp Clinical Communications Limited has no subsidiary companies.
Ultimate parent company
ACP CLINICAL COMMUNICATIONS LIMITED
07933977
acp clinical communications limited directors
Acp Clinical Communications Limited currently has 1 director, Dr Anita Chadha-Patel serving since Feb 2012.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Anita Chadha-Patel | United Kingdom | 49 years | Feb 2012 | - | Director |
P&L
January 2024turnover
1.7m
-5%
operating profit
205.6k
0%
gross margin
21.6%
+0.73%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
January 2024net assets
1.2m
+0.15%
total assets
1.3m
+0.15%
cash
0
0%
net assets
Total assets minus all liabilities
acp clinical communications limited company details
company number
07933977
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
February 2012
age
12
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
January 2024
previous names
N/A
accountant
RUSKELLS LIMITED
auditor
-
address
the tall house 29a west street, marlow, buckinghamshire, SL7 2LS
Bank
-
Legal Advisor
-
acp clinical communications limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to acp clinical communications limited.
acp clinical communications limited Companies House Filings - See Documents
| date | description | view/download |
|---|
